Steven Hyman is of Cyclerion Therapeutics, Inc.. Currently has a direct ownership of 20,000 shares of CYCN, which is worth approximately $46,600. The most recent transaction as insider was on Nov 30, 2023, when has been sold 20,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
0% 3M change
n/a 12M change
Total Value Held $46,600

Steven Hyman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 50.0%
20,000 Common Stock

Also insider at

VYGR
Voyager Therapeutics, Inc. Healthcare
SH

Steven Hyman

Cambridge, MA

Track Institutional and Insider Activities on CYCN

Follow Cyclerion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCN shares.

Notify only if

Insider Trading

Get notified when an Cyclerion Therapeutics, Inc. insider buys or sells CYCN shares.

Notify only if

News

Receive news related to Cyclerion Therapeutics, Inc.

Track Activities on CYCN